Carotid artery stenting under dual antiplatelet therapy using prasugrel: a novel antiplatelet agent

DOI Web Site Web Site 1 Citations 16 References

Bibliographic Information

Other Title
  • 新規抗血小板薬プラスグレルを併用したdual antiplatelet therapy 下での頚動脈ステント留置術
  • 症例報告 新規抗血小板薬プラスグレルを併用したdual antiplatelet therapy下での頚動脈ステント留置術
  • ショウレイ ホウコク シンキ コウケッショウバンヤク プラスグレル オ ヘイヨウ シタ dual antiplatelet therapy カ デ ノ ケイドウミャク ステント リュウチジュツ

Search this article

Description

Objective: Dual antiplatelet therapy is recommended for carotid artery stenting (CAS) to prevent ischemic complications. We report a case of CAS where the novel antiplatelet agent, prasugrel, was used because multiple antiplatelet agents were unavailable.<br/>Case presentation: A 70-year-old man presented with minor stroke associated with cervical carotid artery stenosis. CAS was considered appropriate as a cerebral revascularization therapy. However, both clopidogrel and cilostazol were contraindicated because they were suspected as causes of agranulocytosis. We performed CAS under dual antiplatelet therapy with aspirin and prasugrel. His postoperative course was uneventful.<br/>Conclusion: We described a successful CAS performed under dual antiplatelet therapy including prasugrel, in Japan. Further investigations would be warranted to address the safety and efficacy of prasugrel in neuroendovascular therapy.

Journal

Citations (1)*help

See more

References(16)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top